Glutalor Exhibits its iWel Mobile Glucose CGM Technology at Virtual ADA (American Diabetes Association) 2020 Conference

Published by Admin D on

Related Posts

News

IWel Health Announces Addition of Former FDA Deputy Commissioner Dr. Michael A Friedman to Its Scientific Board

IWel Health announces addition of Michael A Friedman, MD, to its Scientific Board. Dr. Friedman is an experienced healthcare leader with a distinguished career in oncology research, regulatory strategy, and public healthcare policy.  He served Read more…

News

Glutalor Medical Announces Grant of US Patent on its Glucose CGM Technology

Glutalor Medical announces one of its US patent applications related to its glucose CGM (continuous glucose monitoring) technology has been granted. Their patent application ” Dynamic Blood Glucose Data Acquiring Device and Host” was granted Read more…

News

Glutalor Medical Announces EU Patent on its Glucose CGM Technology Granted

Glutalor Medical announces one of its EU Patent applications related to its glucose CGM (continuous glucose monitoring) technology has been granted. Their patent application ” CONTINUOUS GLUCOSE MONITORING SYSTEM AND MONITORING TERMINAL” was granted in Read more…